Analystreport

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview